4Filing Date: Jun 30, 2026
Vertex (VRTX)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0000875320-26-000239
Total Value$287.6K
Trades1
Insiders1
Transaction Details
Bozic Carmen
EVP and CMO·Direct
Sell · Dispose
Common Stock
Shares-596
Price$482.50
Total Value$287.6K
Shares Owned After15.34K
Transaction DateJun 26, 2026
10b5-1
Footnotes ▸
Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025.
Post-Transaction Holdings
Bozic Carmen · EVP and CMO
| Security | Shares | Change |
|---|---|---|
| Common Stock | 15.34K | -596 (-3.74%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-06-26
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
--- Reporting Owner ---
Name: Bozic Carmen
CIK: 0001790029
Role: Officer (EVP and CMO)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-06-26 | Code: S (Open market sale)
Shares: -596 | Price: $482.50
Total Value: $287,570.00
Shares Owned After: 15,337 | Ownership: D (Direct)
Footnotes:
[F1] Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025.
--- Footnotes (Complete Index) ---
F1: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025.
--- Signature ---
/s/ /s/ Christiana Stevenson, Attorney-in-Fact (2026-06-30)